Carvedilol phosphate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

卡维地洛是一种非选择性β受体阻滞剂，适用于治疗轻度至中度充血性心力衰竭（CHF）。

Carvedilol is a non-selective beta blocker indicated in the treatment of mild to moderate congestive heart failure (CHF). It blocks beta-1 and beta-2 adrenergic receptors as well as the alpha-1 adrenergic receptors.

Superoxide generation by activated human neutrophils in vitro is inhibited by Carvedilol with an IC50 of 28 μM. Carvedilol is shown to scavenge oxygen free radicals in a cell-free system with an IC50 of 25 μM.

——

——

Endocrinology/Hormones

Adrenergic Receptor

Adrenergic Receptor| Gap Junction Protein| E-selectin| NADPH dehydrogenase| Natriuretic peptides B| VCAM1| Potassium Channel| VEGFR

Cardiovascular Disease

——

610309-89-2

522.49

C24H26N2O4·H2O·H3O4P

>98% (HPLC)

Water: 10 mM

O.OP(O)(O)=O.COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2

——

(-20℃)

With Ice Pack

≥ 2 years